Company Filing History:
Years Active: 2009-2017
Title: The Innovative Contributions of Elizabeth Mansfield
Introduction
Elizabeth Mansfield is a prominent inventor based in Bethesda, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of recombinant antibodies and immunoconjugates. With a total of 2 patents, her work has advanced the understanding and treatment of malignant B cells.
Latest Patents
Mansfield's latest patents include groundbreaking inventions related to anti-CD22 antibodies. The first patent focuses on methods and compositions relating to anti-CD22 antibodies with high binding affinity, as well as immunoconjugates that link the anti-CD22 antibody to therapeutic agents such as exotoxins or detectable labels. This invention provides diagnostic methods and means to inhibit the growth of malignant B cells. The second patent similarly addresses recombinant anti-CD22 antibodies with high binding affinity and their applications in targeting CD-22 bearing cells and tumors.
Career Highlights
Elizabeth Mansfield works for the United States of America, as represented by the Secretary, Department of Health and Human Services. Her career is marked by a commitment to advancing medical science through innovative research and development.
Collaborations
Mansfield has collaborated with notable colleagues, including David J FitzGerald and Ira H Pastan. These partnerships have further enhanced her research and contributed to the success of her inventions.
Conclusion
Elizabeth Mansfield's contributions to biotechnology through her patents on anti-CD22 antibodies demonstrate her dedication to improving diagnostic and therapeutic methods for cancer treatment. Her work continues to impact the field significantly.